Unitedhealth Group Inc (UNH) concluded trading on Thursday at a closing price of $487.72, with 4.56 million shares of worth about $2.23 billion changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -18.53% during that period and on March 06, 2025 the price saw a gain of about 2.47%. Currently the company’s common shares owned by public are about 915.00M shares, out of which, 912.74M shares are available for trading.
Stock saw a price change of 4.09% in past 5 days and over the past one month there was a price change of -10.58%. Year-to-date (YTD), UNH shares are showing a performance of -3.59% which increased to 1.21% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $436.38 but also hit the highest price of $630.73 during that period. The average intraday trading volume for Unitedhealth Group Inc shares is 5.73 million. The stock is currently trading -1.78% below its 20-day simple moving average (SMA20), while that difference is down -5.00% for SMA50 and it goes to -10.62% lower than SMA200.
Unitedhealth Group Inc (NYSE: UNH) currently have 915.00M outstanding shares and institutions hold larger chunk of about 89.73% of that.
The stock has a current market capitalization of $446.12B and its 3Y-monthly beta is at 0.69. PE ratio of stock for trailing 12 months is 31.39, while it has posted earnings per share of $15.54 in the same period. Its PEG reads 2.79 while making debt-to-equity ratio of 0.88. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for UNH, volatility over the week remained 2.60% while standing at 2.89% over the month.
Stock’s fiscal year EPS is expected to rise by 7.45% while it is estimated to increase by 12.73% in next year. EPS is likely to grow at an annualized rate of 11.24% for next 5-years, compared to annual growth of 1.60% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by HSBC Securities on January 10, 2025 offering a Buy rating for the stock and assigned a target price of $595 to it. Coverage by Truist stated Unitedhealth Group Inc (UNH) stock as a Buy in their note to investors on January 06, 2025, suggesting a price target of $610 for the stock. On October 17, 2024, HSBC Securities Downgrade their recommendations, while on October 11, 2024, KeyBanc Capital Markets Initiated their ratings for the stock with a price target of $675. Stock get a Buy rating from Jefferies on July 17, 2024.
